This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: Kyung S Lee: Innovator in Anticancer Therapeutics
Introduction
Kyung S Lee is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel compounds for therapeutic use. With a total of 3 patents, his work focuses on innovative approaches to cancer treatment.
Latest Patents
Kyung S Lee's latest patents include groundbreaking inventions such as peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use. These novel compounds are designed to bind to polo-like kinases through the polo-box domain, demonstrating high PBD-binding affinity. In certain embodiments, the compounds are PEGylated peptides that have shown efficacy in whole cell systems. Another significant patent involves peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain, which may serve as anticancer therapeutics. These compounds are designed to possess an overall neutral charge, enhancing their bioavailability and efficacy.
Career Highlights
Kyung S Lee is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on innovative research that has the potential to impact cancer treatment significantly.
Collaborations
Throughout his career, Kyung S Lee has collaborated with notable colleagues, including Terrence R Burke, Jr and Fa Liu. These collaborations have contributed to the advancement of his research and the development of his patented inventions.
Conclusion
Kyung S Lee is a dedicated inventor whose work in the field of anticancer therapeutics is paving the way for new treatment options. His innovative patents and collaborations highlight his commitment to advancing medical science.